KIT and cancer: Both HO8910 CD44+CD117+ cell and ID8 cancer stem-like cell vaccinations provided significant protection against the tumor cell challenges and inhibited the growth of tumor cells as xenografts in nude mice or as allografts in C57BL/6 mice compared to the control vaccinations.